https://librepathology.org/w/index.php?action=history&feed=atom&title=Dihydropyrimidine_dehydrogenase_deficiency 2026-09-21T22:28:00Z Revision history for this page on the wiki MediaWiki 1.43.9 https://librepathology.org/w/index.php?title=Dihydropyrimidine_dehydrogenase_deficiency&diff=52670&oldid=prev 2024-02-23T16:08:42Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:08, 23 February 2024</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''Dihydropyrimidine dehydrogenase deficiency''', abbreviated '''DPD''', is an enzyme deficiency that is associated with toxicity to 5-fluorouracil.&lt;ref&gt;{{cite journal |authors=Ezzeldin H, Diasio R |title=Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration |journal=Clin Colorectal Cancer |volume=4 |issue=3 |pages=181–9 |date=September 2004 |pmid=15377401 |doi=10.3816/ccc.2004.n.018 |url=}}&lt;/ref&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''Dihydropyrimidine dehydrogenase deficiency''', abbreviated '''DPD''', is an enzyme deficiency that is associated with toxicity to 5-fluorouracil <ins style="font-weight: bold; text-decoration: none;">(5-FU)</ins>.&lt;ref&gt;{{cite journal |authors=Ezzeldin H, Diasio R |title=Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration |journal=Clin Colorectal Cancer |volume=4 |issue=3 |pages=181–9 |date=September 2004 |pmid=15377401 |doi=10.3816/ccc.2004.n.018 |url=}}&lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==See also==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==See also==</div></td></tr> <!-- diff cache key wikidb2:diff:1.41:old-52669:rev-52670:php=table --> </table>

Michael https://librepathology.org/w/index.php?title=Dihydropyrimidine_dehydrogenase_deficiency&diff=52669&oldid=prev 2024-02-23T16:07:32Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:07, 23 February 2024</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''Dihydropyrimidine dehydrogenase deficiency''' is an enzyme deficiency that is associated with toxicity to 5-fluorouracil.&lt;ref&gt;{{cite journal |authors=Ezzeldin H, Diasio R |title=Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration |journal=Clin Colorectal Cancer |volume=4 |issue=3 |pages=181–9 |date=September 2004 |pmid=15377401 |doi=10.3816/ccc.2004.n.018 |url=}}&lt;/ref&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''Dihydropyrimidine dehydrogenase deficiency'''<ins style="font-weight: bold; text-decoration: none;">, abbreviated '''DPD''', </ins>is an enzyme deficiency that is associated with toxicity to 5-fluorouracil.&lt;ref&gt;{{cite journal |authors=Ezzeldin H, Diasio R |title=Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration |journal=Clin Colorectal Cancer |volume=4 |issue=3 |pages=181–9 |date=September 2004 |pmid=15377401 |doi=10.3816/ccc.2004.n.018 |url=}}&lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==See also==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==See also==</div></td></tr> </table>

Michael https://librepathology.org/w/index.php?title=Dihydropyrimidine_dehydrogenase_deficiency&diff=52668&oldid=prev 2024-02-23T16:06:48Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:06, 23 February 2024</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''Dihydropyrimidine dehydrogenase deficiency''' is an enzyme deficiency that is associated with toxicity to 5-fluorouracil.&lt;ref&gt;{{cite journal |<del style="font-weight: bold; text-decoration: none;">vauthors</del>=Ezzeldin H, Diasio R |title=Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration |journal=Clin Colorectal Cancer |volume=4 |issue=3 |pages=181–9 |date=September 2004 |pmid=15377401 |doi=10.3816/ccc.2004.n.018 |url=}}&lt;/ref&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''Dihydropyrimidine dehydrogenase deficiency''' is an enzyme deficiency that is associated with toxicity to 5-fluorouracil.&lt;ref&gt;{{cite journal |<ins style="font-weight: bold; text-decoration: none;">authors</ins>=Ezzeldin H, Diasio R |title=Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration |journal=Clin Colorectal Cancer |volume=4 |issue=3 |pages=181–9 |date=September 2004 |pmid=15377401 |doi=10.3816/ccc.2004.n.018 |url=}}&lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==See also==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==See also==</div></td></tr> </table>

Michael https://librepathology.org/w/index.php?title=Dihydropyrimidine_dehydrogenase_deficiency&diff=52667&oldid=prev 2024-02-23T16:06:36Z

<p>create</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Dihydropyrimidine dehydrogenase deficiency&#039;&#039;&#039; is an enzyme deficiency that is associated with toxicity to 5-fluorouracil.&lt;ref&gt;{{cite journal |vauthors=Ezzeldin H, Diasio R |title=Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration |journal=Clin Colorectal Cancer |volume=4 |issue=3 |pages=181–9 |date=September 2004 |pmid=15377401 |doi=10.3816/ccc.2004.n.018 |url=}}&lt;/ref&gt;<br /> <br /> ==See also==<br /> *[[Colorectal carcinoma]].<br /> <br /> ==References==<br /> {{Reflist|1}}<br /> <br /> [[Category:Clinical]]</div>

Michael